Decreased Esophageal Sensitivity to Acid in Morbidly Obese Patients: A Cause for Concern?
0
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background/Aims: To evaluate esophageal sensitivity to acid between morbidly obese (MO) patients and non-MO controls with abnormal esophageal acid exposure. Methods: We conducted a cross-sectional study of 58 patients: 30 MO (cases) and 28 non-MO (controls). Esophageal symptoms and esophageal sensitivity to 0.1 M hydrochloric acid solution (Bernstein test) were compared between MO and non- MO patients with a prior diagnosis of abnormal esophageal acid exposure. Results: MO patients were less symptomatic than non-MO controls (14% vs 96%; odds ratio [OR], 0.006; 95% confidence interval [CI], 0.001 to 0.075; p=0.000). MO patients were more likely to present with decreased esophageal sensitivity to the instillation of acid than non-MO controls (57% vs 14%; OR, 8; 95% CI, 1.79 to 35.74; p=0.009). Subgroup analysis revealed no differences in esophageal sensitivity in MO patients with and without abnormal esophageal acid exposure (43% vs 31%; p=0.707). Conclusions: Silent gastroesophageal reflux disease (GERD) is common among MO individuals, likely due to decreased esophageal sensitivity to acid. The absence of typical GERD symptoms in these patients may delay discovery of precancerous conditions, such as Barrett’s esophagus. We believe that these patients may require a more aggressive diagnostic work-up to rule out the presence of silent GERD.
Abstract
Background/Aims: To evaluate esophageal sensitivity to acid between morbidly obese (MO) patients and non-MO controls with abnormal esophageal acid exposure. Methods: We conducted a cross-sectional study of 58 patients: 30 MO (cases) and 28 non-MO (controls). Esophageal symptoms and esophageal sensitivity to 0.1 M hydrochloric acid solution (Bernstein test) were compared between MO and non- MO patients with a prior diagnosis of abnormal esophageal acid exposure. Results: MO patients were less symptomatic than non-MO controls (14% vs 96%; odds ratio [OR], 0.006; 95% confidence interval [CI], 0.001 to 0.075; p=0.000). MO patients were more likely to present with decreased esophageal sensitivity to the instillation of acid than non-MO controls (57% vs 14%; OR, 8; 95% CI, 1.79 to 35.74; p=0.009). Subgroup analysis revealed no differences in esophageal sensitivity in MO patients with and without abnormal esophageal acid exposure (43% vs 31%; p=0.707). Conclusions: Silent gastroesophageal reflux disease (GERD) is common among MO individuals, likely due to decreased esophageal sensitivity to acid. The absence of typical GERD symptoms in these patients may delay discovery of precancerous conditions, such as Barrett’s esophagus. We believe that these patients may require a more aggressive diagnostic work-up to rule out the presence of silent GERD.
참고문헌 (30)
- Hedley AA, "Prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002", JAMA, 291, pp.2847~2850 (2004)
- National Institutes of Health, "Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: the evidence report", Obes Res, 6(Suppl 2), pp.51S~209S (1998)
- Pi-Sunyer FX, "Medical hazards of obesity", Ann Intern Med, 119(7 Pt 2), pp.655~660 (1993)
- National Task Force on the Prevention and Treatment of Obesity, "Overweight, obesity, and health risk", Arch Intern Med, 160, pp.898~904 (2000)
- Klein S, "AGA technical review on obesity", Gastroenterology, 123, pp.882~932 (2002)
- Calle EE, "Bodymass index and mortality in a prospective cohort of U.S. adults", N Engl J Med, 341, pp.1097~1105 (1999)
- Fontaine KR, "Years of life lost due to obesity", JAMA, 289, pp.187~193 (2003)
- Peeters A, "Obesity in adulthood and its consequences for life expectancy: a life-table analysis", Ann Intern Med, 138, pp.24~32 (2003)
- Döring N, "The associations between overweight, weight change and health related quality of life: longitudinal data from the Stockholm public health cohort 2002- 2010", Prev Med, 75, pp.12~17 (2015)
- López-García E, "Relation between body weight and health-related quality of life among the elderly in Spain", Int J Obes Relat Metab Disord, 27, pp.701~709 (2003)
- Dent J, "Epidemiology of gastro-oesophageal reflux disease: a systematic review", Gut, 54, pp.710~717 (2005)
- Ponce J, "Prevalence of gastro-oesophageal reflux disease in Spain and associated factors", Aliment Pharmacol Ther, 23, pp.175~184 (2006)
- Murray L, "Relationship between body mass and gastro-oesophageal reflux symptoms: the Bristol Helicobacter project", Int J Epidemiol, 32, pp.645~650 (2003)
- Nilsson M, "Obesity and estrogen as risk factors for gastroesophageal reflux symptoms", JAMA, 290, pp.66~72 (2003)
- Rey E, "Association between weight gain and symptoms of gastroesophageal reflux in the general population", Am J Gastroenterol, 101, pp.229~233 (2006)
- El-Serag HB, "Obesity is an independent risk factor for GERD symptoms and erosive esophagitis", Am J Gastroenterol, 100, pp.1243~1250 (2005)
- Ortiz V, "Value of heartburn for diagnosing gastroesophageal reflux disease in severely obese patients", Obesity (Silver Spring), 14, pp.696~700 (2006)
- Ponce J, "Individual prediction of response to pneumatic dilation in patients with achalasia", Dig Dis Sci, 41, pp.2135~2141 (1996)
- Garrigues V, "Manifestations of gastroesophageal reflux and response to omeprazole therapy in patients with chronic posterior laryngitis: an evaluation based on clinical practice", Dig Dis Sci, 48, pp.2117~2123 (2003)
- Lundell LR, "Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification", Gut, 45, pp.172~180 (1999)
- Barak N, "Gastro-oesophageal reflux disease in obesity: pathophysiological and therapeutic considerations", Obes Rev, 3, pp.9~15 (2002)
- El-Serag H, "The association between obesity and GERD: a review of the epidemiological evidence", Dig Dis Sci, 53, pp.2307~2312 (2008)
- Jaffin BW, "High prevalence of asymptomatic esophageal motility disorders among morbidly obese patients", Obes Surg, 9, pp.390~395 (1999)
- Hong D, "Manometric abnormalities and gastroesophageal reflux disease in the morbidly obese", Obes Surg, 14, pp.744~749 (2004)
- Suter M, "Gastro-esophageal reflux and esophageal motility disorders in morbidly obese patients", Obes Surg, 14, pp.959~966 (2004)
- Hong D, "Assessment of the afferent vagal nerve in patients with gastroesophageal reflux", Surg Endosc, 16, pp.1042~1045 (2002)
- Peterson HR, "Body fat and the activity of the autonomic nervous system", N Engl J Med, 318, pp.1077~1083 (1988)
- Geliebter A, "Gastric distention by balloon and test-meal intake in obese and lean subjects", Am J Clin Nutr, 48, pp.592~594 (1988)
- Hiroto Miwa, "Esophageal Sensation and Esophageal Hypersensitivity - Overview From Bench to Bedside", Journal of Neurogastroenterology and Motility (JNM), 16(4), pp.353~362 (2010), 대한소화기 기능성질환∙운동학회
- Akyüz F, "Gastroesophageal reflux in asymptomatic obese subjects: an esophageal impedance-pH study", World J Gastroenterol, 21, pp.3030~3034 (2015)